Charitable trust registration requires a specified-violation notice; settled cash deposits and related-party payments did not justify cancellation or ...
External development charges trigger TDS under section 194C, while disputed administrative payments require factual verification and fresh adjudicatio...
Section 270AA penalty immunity requires identified statutory defaults and a hearing before rejection; reassessment disclosure may constitute under-rep...
Section 80JJAA employee-cost deduction allowed for deployed staff but barred against transfer-pricing income enhancement, with pricing issues remanded...
Transfer-pricing methodology protects commercially genuine associated-enterprise payments, while pre-2016 secondary adjustments and related notional i...
Negative liens over operating assets can constitute international transactions requiring arm's-length pricing reflecting restricted borrowing and expa...
Cross-examination rights in Customs Broker revocation inquiries require witness examination; procedural denial may be cured through fresh adjudication...
The HC directed the first and second respondents to permit clearance of the petitioner's imported ayurvedic drug consignment subject to compliance with statutory standards under the Drugs & Cosmetics Act and Rules. Recognizing the applicability of the statute to ayurvedic drugs and the absence of specific import rules, the court mandated testing of the product by a CDSCO-accredited laboratory under the supervision of the fifth respondent, the licensing authority for ayurvedic drugs. The petitioner must bear all testing costs. Upon receipt of a satisfactory laboratory report certifying conformity with Indian manufacturing standards, the fifth respondent shall issue a certificate to the first and second respondents, who shall then allow release of the goods covered by the relevant bill of entry. The petition was accordingly disposed of, ensuring regulatory compliance while facilitating import clearance.
The HC directed the first and second respondents to permit clearance of the petitioner's imported ayurvedic drug consignment subject to compliance with statutory standards under the Drugs & Cosmetics Act and Rules. Recognizing the applicability of the statute to ayurvedic drugs and the absence of specific import rules, the court mandated testing of the product by a CDSCO-accredited laboratory under the supervision of the fifth respondent, the licensing authority for ayurvedic drugs. The petitioner must bear all testing costs. Upon receipt of a satisfactory laboratory report certifying conformity with Indian manufacturing standards, the fifth respondent shall issue a certificate to the first and second respondents, who shall then allow release of the goods covered by the relevant bill of entry. The petition was accordingly disposed of, ensuring regulatory compliance while facilitating import clearance.
Note: It is a system-generated summary and is for quick reference only.